E. Ileana

Antitumour activity of abiraterone acetate against metastatic castration-resistant prostate cancer progressing after docetaxel and enzalutamide (MDV3100)

Yohann Loriot, Diletta Bianchini, E. Ileana et al. · Annals of Oncology · 2013 · 356 citations · Full text

Medicine, Oncology, Pharmacology +16

Who dies from prostate cancer?

Anna Patrikidou, Yohann Loriot, J-C. Eymard et al. · Prostate Cancer and Prostatic Diseases · 2014 · 86 citations

Medicine, Oncology, Urology +12

Antitumor activity in advanced cancer patients with thymic malignancies enrolled in early clinical drug development programs (Phase I trials) at Gustave Roussy

Myriam Kossaï, Boris Duchemann, C. Boutros et al. · Lung Cancer · 2015 · 15 citations

Medicine, Oncology, Pharmacology +11

Seeking the driver in tumours with apparent normal molecular profile on comparative genomic hybridization and targeted gene panel sequencing: what is the added value of whole exome sequencing?

Sophie Postel‐Vinay, Yannick Boursin, Christophe Massard et al. · Annals of Oncology · 2015 · 13 citations · Full text

Life Sciences, Genetics, Oncology +17

Phase I study of temsirolimus in combination with cetuximab in patients with advanced solid tumours

Antoine Hollebecque, Rastilav Bahleda, Laurence Faivre et al. · European Journal of Cancer · 2017 · 11 citations

Medicine, Oncology, Pharmacotherapy +8